Literature DB >> 19184538

Lysophosphatidic acid and autotaxin: emerging roles in innate and adaptive immunity.

Steve N Georas1.   

Abstract

Lysophosphatidic acid (LPA) can affect the growth, migration, and activation of many different cell types. Research in this field has recently accelerated due to the molecular cloning of LPA receptors as well as advances in our understanding of LPA metabolism. A major pathway for LPA generation is the hydrolysis of lysophosphatidylcholine by the enzyme autotaxin (ATX). Although most research to-date has been conducted in other disciplines (e.g., neurobiology and cardiovascular diseases), emerging data point to an important role for LPA and ATX in regulating immune responses. Here we review current understanding of LPA and ATX in immunity with an emphasis on migration and activation of lymphocytes and dendritic cells. New gene-targeted and transgenic mice, receptor-specific antibodies, and pathway antagonists should rapidly enhance our understanding of this versatile lysolipid in immune responses in the near future.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19184538     DOI: 10.1007/s12026-009-8104-y

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  59 in total

1.  Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.

Authors:  Suzanne Mandala; Richard Hajdu; James Bergstrom; Elizabeth Quackenbush; Jenny Xie; James Milligan; Rosemary Thornton; Gan-Ju Shei; Deborah Card; CarolAnn Keohane; Mark Rosenbach; Jeffrey Hale; Christopher L Lynch; Kathleen Rupprecht; William Parsons; Hugh Rosen
Journal:  Science       Date:  2002-03-28       Impact factor: 47.728

Review 2.  Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs.

Authors:  Jason G Cyster
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

3.  GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5.

Authors:  Chang-Wook Lee; Richard Rivera; Shannon Gardell; Adrienne E Dubin; Jerold Chun
Journal:  J Biol Chem       Date:  2006-06-14       Impact factor: 5.157

4.  Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate.

Authors:  Laurens A van Meeteren; Paula Ruurs; Evangelos Christodoulou; James W Goding; Hideo Takakusa; Kazuya Kikuchi; Anastassis Perrakis; Tetsuo Nagano; Wouter H Moolenaar
Journal:  J Biol Chem       Date:  2005-03-15       Impact factor: 5.157

5.  Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior.

Authors:  J J Contos; N Fukushima; J A Weiner; D Kaushal; J Chun
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

6.  LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation.

Authors:  Chang-Wook Lee; Richard Rivera; Adrienne E Dubin; Jerold Chun
Journal:  J Biol Chem       Date:  2006-12-13       Impact factor: 5.157

Review 7.  Sharpening the edges of understanding the structure/function of the LPA1 receptor: expression in cancer and mechanisms of regulation.

Authors:  Mandi M Murph; Giang H Nguyen; Harish Radhakrishna; Gordon B Mills
Journal:  Biochim Biophys Acta       Date:  2008-04-29

8.  Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate.

Authors:  Rajita Pappu; Susan R Schwab; Ivo Cornelissen; João P Pereira; Jean B Regard; Ying Xu; Eric Camerer; Yao-Wu Zheng; Yong Huang; Jason G Cyster; Shaun R Coughlin
Journal:  Science       Date:  2007-03-15       Impact factor: 47.728

9.  LPA modulates monocyte migration directly and via LPA-stimulated endothelial cells.

Authors:  Cindy Gustin; Martine Van Steenbrugge; Martine Raes
Journal:  Am J Physiol Cell Physiol       Date:  2008-07-16       Impact factor: 4.249

Review 10.  Sphingosine 1-phosphate, lysophosphatidic acid and growth factor signaling and termination.

Authors:  Nigel J Pyne; Susan Pyne
Journal:  Biochim Biophys Acta       Date:  2008-06-17
View more
  11 in total

Review 1.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

2.  Lpa2 is a negative regulator of both dendritic cell activation and murine models of allergic lung inflammation.

Authors:  Jason Emo; Nida Meednu; Timothy J Chapman; Fariba Rezaee; Marlene Balys; Troy Randall; Tirumalai Rangasamy; Steve N Georas
Journal:  J Immunol       Date:  2012-03-16       Impact factor: 5.422

Review 3.  Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression.

Authors:  Lorenzo Federico; Kang Jin Jeong; Christopher P Vellano; Gordon B Mills
Journal:  J Lipid Res       Date:  2015-05-14       Impact factor: 5.922

Review 4.  Role of autotaxin in cancer stem cells.

Authors:  Dongjun Lee; Dong-Soo Suh; Sue Chin Lee; Gabor J Tigyi; Jae Ho Kim
Journal:  Cancer Metastasis Rev       Date:  2018-09       Impact factor: 9.264

5.  Natural forms of vitamin E and 13'-carboxychromanol, a long-chain vitamin E metabolite, inhibit leukotriene generation from stimulated neutrophils by blocking calcium influx and suppressing 5-lipoxygenase activity, respectively.

Authors:  Ziying Jiang; Xinmin Yin; Qing Jiang
Journal:  J Immunol       Date:  2010-12-17       Impact factor: 5.422

6.  Autotaxin is induced by TSA through HDAC3 and HDAC7 inhibition and antagonizes the TSA-induced cell apoptosis.

Authors:  Song Li; Baolu Wang; Yan Xu; Junjie Zhang
Journal:  Mol Cancer       Date:  2011-02-12       Impact factor: 27.401

7.  Prostatic acid phosphatase, a neglected ectonucleotidase.

Authors:  Herbert Zimmermann
Journal:  Purinergic Signal       Date:  2009-03-26       Impact factor: 3.765

8.  Plasma proteome analysis reveals overlapping, yet distinct mechanisms of immune activation in chronic HCV and HIV infections.

Authors:  Daniela M Schlatzer; Julia M Sugalski; Yanwen Chen; Jill Barnholtz-Sloan; Perica Davitkov; Fred E Hazlett; Nicholas Funderburg; Benigno Rodriguez; Michael M Lederman; Scott F Sieg; Mark R Chance; Donald D Anthony
Journal:  J Acquir Immune Defic Syndr       Date:  2013-08-15       Impact factor: 3.731

9.  Immunology at the university of Rochester.

Authors:  Edith M Lord
Journal:  Immunol Res       Date:  2009-02-25       Impact factor: 2.829

10.  Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling.

Authors:  Vivek Rai; Fatouma Touré; Seth Chitayat; Renjun Pei; Fei Song; Qing Li; Jinghua Zhang; Rosa Rosario; Ravichandran Ramasamy; Walter J Chazin; Ann Marie Schmidt
Journal:  J Exp Med       Date:  2012-12-03       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.